abstract |
The present invention relates to compounds of formula I, stereoisomers, enantiomers, pharmaceutically acceptable salts or amino acid conjugates thereof, wherein the variables in formula (I) are as defined herein; the invention also relates to their pharmaceutical use The compositions, compounds and pharmaceutical compositions of the present invention can be used as modulators of farnesoid X receptor (FXR) activity. |